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Faculty of Engineering and Industrial Sciences, Swinburne University of Technology, Hawthorn, AustraliaABSTRACT The serotonin1A receptor is a representative member of the GPCR superfamily and serves as an important drug
target. The possible role of GPCR oligomerization in receptor function is an active area of research. We monitored the oligomer-
ization state of serotonin1A receptors using homo-FRET and fluorescence lifetime measurements. Homo-FRET is estimated by
a reduction in fluorescence anisotropy and provides a superior approach for exploring oligomerization. In addition, homo-FRET
offers the possibility of detecting higher-order oligomers. On the basis of an observed increase in fluorescence anisotropy upon
progressive photobleaching and analysis of the difference between the extrapolated anisotropy and the predicted anisotropy of
an immobile monomer, we propose the presence of constitutive oligomers of the serotonin1A receptor. To the best of our knowl-
edge, these results constitute the first report of higher-order oligomers for the serotonin1A receptor. We further show that choles-
terol depletion and antagonist treatment result in a reduced population of higher-order oligomers. In contrast, agonist stimulation
and destabilization of the actin cytoskeleton lead to an increased contribution from higher oligomers. These results provide novel
insight into the oligomerization status of the serotonin1A receptor that could enhance the ability to design better therapeutic
strategies to combat diseases related to malfunctioning of GPCRs.INTRODUCTIONThe GPCR superfamily is the largest and most diverse
protein family in mammals, involved in signal transduction
across membranes (1). Cellular signaling by GPCRs
requires their activation by ligands present in the extracel-
lular environment and the subsequent transduction of
signals to the interior of the cell through concerted changes
in their transmembrane domain structure. GPCRs mediate
multiple physiological processes, including neurotransmis-
sion, cellular metabolism, secretion, cellular differentiation,
growth, and inflammatory and immune responses. It is
therefore only natural that GPCRs have emerged as major
targets for the development of novel drug candidates in all
clinical areas, and account for ~50% of current drug targets
(2). The serotonin1A (5-HT1A) receptor is an important
member of the GPCR superfamily and is the most exten-
sively studied among the serotonin receptors, for a variety
of reasons (3). The serotonin1A receptor agonists and antag-
onists have been shown to have potential therapeutic effects
in anxiety or stress-related disorders (3). As a result, the
serotonin1A receptor serves as an important target in theSubmitted September 10, 2010, and accepted for publication December 8,
2010.
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Aggregation and oligomerization have often been chal-
lenging yet exciting aspects in the study of membrane
proteins. An emerging area is the possible role of oligomer-
ization in GPCR organization and signaling (4–8). The
potential implications of such oligomerization are far-reach-
ing, especially considering the role of GPCRs as major drug
targets (9). Fluorescence-based resonance energy transfer
methods such as hetero-FRET and bioluminescence reso-
nance energy transfer have been used to study GPCR oligo-
merization in live cell membranes (8). However, these
techniques are often associated with a number of inherent
complications arising from the use of receptors conjugated
to two different probes, and a lack of control in their relative
expression levels (10,11). Hetero-FRET measurements are
performed utilizing using two different fluorophores with
sufficient spectral overlap. In the case of heterologously ex-
pressed proteins, the expression levels of the tagged proteins
may vary, making intensity-based hetero-FRET measure-
ments difficult to interpret. These factors have limited the
usefulness of these approaches for providing information
about GPCR biology. In comparison with hetero-FRET,
homo-FRET represents a superior approach. Homo-FRET
is a simpler variant of energy transfer because it takes place
between like fluorophores and therefore requires only
a single type of fluorophore. Homo-FRET (FRET between
two identical fluorophores) depends on the inverse sixth
power of separation between interacting fluorophores on
the nanometer scale and thus is sensitive to protein oligo-
merization. The excitation and emission spectra of fluoro-
phores exhibiting homo-FRET should have considerabledoi: 10.1016/j.bpj.2010.12.3692
362 Ganguly et al.overlap. In other words, fluorophores with a relatively small
Stokes shift will have a greater probability of undergoing
homo-FRET. In addition, homo-FRET is manifested by
a reduction in fluorescence anisotropy, a parameter that is
largely independent of the concentration of fluorophores
(12). Another serious limitation of hetero-FRET measure-
ments is the lack of ability to distinguish dimers from
higher-order oligomers. This is often crucial, particularly
in a microheterogeneous environment such as the mem-
brane, where multiple types of oligomeric clusters can
coexist. Fortunately, homo-FRET measurements can pro-
vide an estimate of higher-order oligomerization (13,14).
In this work, we explored the oligomerization state of the
serotonin1A receptor by performing homo-FRETand fluores-
cence lifetimemeasurements on CHO cells stably expressing
the EYFP-tagged serotonin1A receptor (5-HT1AR-EYFP).
Spatial resolution was achieved by using amicroscope-based
approach and homo-FRETwas monitored by the increase in
fluorescence anisotropy upon progressive photobleaching of
the receptor. In anisotropy enhancement after photobleach-
ingmeasurements, fluorescence depolarization due to energy
transfer is prevented by photobleaching of FRET acceptors
(15). We show here that analysis of the progressive enhance-
ment in anisotropy due to increasing photobleaching
provides evidence for the existence of constitutive seroto-
nin1A receptor oligomers. We further report the effects of
ligands, cholesterol depletion, and cytoskeletal disruption
on receptor oligomerization.
MATERIALS AND METHODS
Materials
MgCl2, p-MPPI, CaCl2, penicillin, streptomycin, gentamicin sulfate, sero-
tonin, MbCD, and CD were obtained from Sigma (St. Louis, MO). Dulbec-
co’s modified Eagle’s medium (DMEM)/F-12 (nutrient mixture F-12, Ham;
1:1)), fetal calf serum, and geneticin (G 418) were obtained from Invitrogen
Life Technologies (Carlsbad, CA). All other chemicals used were of the
highest available purity. Water was purified through a Millipore (Bedford,
MA) Milli-Q system and used throughout.
Cells and cell culture
CHO-K1 cells stably expressing the serotonin1A receptor tagged to EYFP
(referred to as CHO-5-HT1AR-EYFP) were used (~10
5 receptors/cell).
Cells were grown on Lab-Tek (Nunc, Denmark) chambers in DMEM/
F-12 (1:1) supplemented with 2.4 g/L of sodium bicarbonate, 10% fetal
calf serum, 60 mg/mL penicillin, 50 mg/mL streptomycin, 50 mg/mL genta-
micin sulfate in a humidified atmosphere with 5% CO2 at 37
C. CHO-5-
HT1AR-EYFP cells were maintained in the above-mentioned conditions
along with 300 mg/mL geneticin.
Treatment of cells
A stock solution of 2 mM CD was made in DMSO, and further concentra-
tions were prepared upon dilution of the stock in buffer A (phosphate-buff-
ered saline containing 1 mM CaCl2 and 0.5 mM MgCl2). The amount of
DMSO was always <0.5% (v/v). Treatment of control cells with similar
amounts of DMSO did not show any change in cellular morphology or
receptor distribution. MbCD was directly dissolved in buffer A to makeBiophysical Journal 100(2) 361–368the desired concentration. Cells were treated with 5 mM CD and 10 mM
MbCD unless otherwise mentioned. For treatment with ligands, 10 mM
serotonin or p-MPPI was used. All experiments were performed at room
temperature (~23C).FLIM experiments
FLIMmeasurements were carried out using a fluorescence lifetime imaging
attachment (LIFA; Lambert Instruments, Leutingwolde, The Netherlands)
mounted on an inverted microscope (TE2000U; Nikon, Japan). The tagged
receptor in livingcellswereexcitedusingepi-illuminationwitha sinusoidally
modulated 470 nm LED at 40 MHz and observed with a 100x (NA 1.25) oil
objective (Nikon Plan-Fluor; Nikon, Japan) through a filter set (Nikon FITC,
DM505, EM 515–555 nm). The phase and modulation lifetimes were deter-
mined from a series of images taken at 12 phase settings using software
provided by the manufacturer. A pseudo random recording order provided
by the softwarewas used to correct for any photobleaching (16). Rhodamine
6G in distilled water (lifetime 4.1 ns) was used as a reference (17). Themean
and standard deviations for the phase and modulation lifetimes reported are
from~20 cells.We averaged the FLIMdata on a cell-to-cell basis becausewe
are interested in the statistics of a cell population.Fluorescence anisotropy imaging microscopy
Anisotropy imaging was performed using the same setup as described for
the FLIM experiments with the inclusion of a polarizer in the excitation
path of the microscope and a dual-view polarizing beam splitter in the emis-
sion path before the LIFA intensifier-CCD camera. CHO-5-HT1AR-EYFP
cells were excited using epi-illumination with a 470 nm LED at constant
illumination (unmodulated) and observed with a 100x (NA 1.25) oil objec-
tive, using a Nikon FITC filter, as described above. The parallel and perpen-
dicular components of the emission were imaged synchronously on both
halves of the CCD chip. Images were recorded at constant illumination
as a function of time with the software provided by the manufacturer.
The images were corrected for instrumental differences in the detection
of parallel and perpendicular components of the emission by using Rhoda-
mine 6G in distilled water as a reference and an anisotropy of 0.012,
measured in a Varian Eclipse spectrofluorometer, as described previously
(18). To correct for the depolarization caused by the high aperture objective
used in this study, Rhodamine 6G was taken in solutions of varying glycerol
content and anisotropies were simultaneously measured under the micro-
scope and a Varian Eclipse spectrofluorometer. The calibration plot of the
measured anisotropy of the same Rhodamine 6G solution under the micro-
scope versus the spectrofluorometer is shown in the inset of Fig. 1. Correc-
tion for aperture depolarization in the microscope was made by multiplying
the anisotropy determined under the microscope by a constant factor of
1.47, derived from the slope.
Individual cells were selected using region-of-interest tools in ImageJ
(National Institutes of Health, Bethesda, MD), and the parallel (Ipar(t)) and
perpendicular (Iperp(t)) intensity values were analyzed as a function of
illumination time. The total fluorescence as a function of time was given by
IðtÞ ¼ IparðtÞ þ 2GIperpðtÞ;
where G is the correction factor for instrumental differences in detection in
the parallel and perpendicular halves of the CCD. The mean anisotropy is
given by
rðtÞ ¼ IparðtÞ  GIperpðtÞ

IðtÞ;
The fractional fluorescence remaining (after time zero) was calculated as
f ðtÞ ¼ ½It¼ 0  It=It¼ 0:
Plots of r(t) versus f(t) were constructed and interpreted using the
theoretical framework of Yeow and Clayton (14) (see the Supporting
FIGURE 1 Enhancement of fluorescence anisotropy upon photobleach-
ing of 5-HT1AR-EYFP in live CHO cells under various conditions. Plots
of corrected anisotropy for untreated cells (C, black) and cells treated
with serotonin (:, red), p-MPPI (;, cyan), CD (-, blue), or MbCD
(A, green) upon photobleaching are shown. The fraction of photobleached
fluorophores was binned (bin width 0.05) and the mean anisotropy and
associated standard error for each bin are plotted. The inset shows the cali-
bration plot for correction of measured anisotropy. The anisotropy values of
Rhodamine 6G in solutions of increasing glycerol concentration measured
in a spectrofluorometer are plotted against the anisotropy values of the
same samples measured under a microscope. The calibration plot shows
an excellent linear correlation (y ¼ 1.4699x  0.0019; R2 ¼ 0.99).
See Materials and Methods for other details.
Organization of Higher-Order GPCR Oligomers 363Material). The fraction of photobleached fluorophores was binned (bin
width 0.05), and the mean anisotropy and associated standard error for
each bin are plotted in Fig. 1. The mean and standard deviations reported
here are from seven to eight cells for each condition, acquired over multiple
sets of measurements. Image arithmetic was performed in ImageJ (National
Institutes of Health). Plotting and analysis were carried out with the use of
Origin software version 7.0 (OriginLab, Northampton, MA) and Microsoft
(Redmond, WA) Excel 2007.TABLE 1 Anisotropy enhancement upon photobleaching of
5-HT1AR-EYFP in live cells
Condition
Anisotropy
Initial (5 SD) Extrapolated
Control 0.2235 0.024 0.313
Serotonin 0.2125 0.026 0.293
p-MPPI 0.2285 0.016 0.326
CD 0.2095 0.034 0.225
MbCD 0.2575 0.023 0.347
See Materials and Methods for other details.RESULTS
Fluorescence anisotropy of 5-HT1AR-EYFP
in live cells
We have earlier characterized the heterologously expressed
serotonin1A receptor tagged to EYFP in CHO cells and
showed that the tagged receptors are essentially similar to
the native receptor (19). To explore fluorophore-fluorophore
interactions due to possible oligomerization, we compared
the previously reported anisotropy of EYFP in solution
with that of 5-HT1AR-EYFP in cells. In a dilute solution,
the steady-state anisotropy would reflect the rotational
motion of the monomeric fluorophore. If the fluorophore
undergoes homo-FRET (for example, due to oligomeriza-
tion), the emission will be depolarized, resulting in a reduced
steady-state anisotropy. Homo-FRET reduces steady-state
anisotropy because energy transfer from an initially excited
fluorophore to one in a different orientation alters theangular distribution of emitting fluorophores from that
produced by photoselection alone. In other words, homo-
FRET leads to depolarization of the emission because of
the lack of correlation between the orientation of the
secondarily excited molecules and that of the initially pho-
toselected donor (20). Therefore, the formation of oligomers
that bring individual 5-HT1AR-EYFP molecules within the
homo-FRET range (~6 nm (21)) can be determined by
measurement of the steady-state anisotropy.
For fluorophore-fluorophore interactions caused by oligo-
merization of the 5-HT1AR-EYFP in the cellular plasma
membrane, rapid anisotropy decay and a correspondingly
lower steady-state anisotropy is predicted. Since the funda-
mental anisotropy (ro) of EYFP is 0.38 (22), we assumed the
fundamental anisotropy (ro) of 5-HT1AR-EYFP to be ~0.38.
Our assumption is based on previous studies in which it was
observed that GFP, when fused at the end of proteins, reports
on segmental rather than whole protein rotational motion
(23,24). Although the steady-state anisotropy of 5-HT1AR-
EYFP is expected to be lower than 0.38 (for example, the
steady-state anisotropy of YFP in solution has been reported
to be ~0.3 (25)), the orientation of the receptor in the plasma
membrane may increase the anisotropy. Therefore, we used
a value for the anisotropy in the absence of homo-FRET,
i.e., the value for rotationally immobile EYFP (0.38). This
is a reasonable approximation because reported anisotropies
of GFP molecules attached to membrane proteins in the
absence of homo-FRET tend to approach this value (0.36
for GFP-tagged EGF receptor (20)). Importantly, the value
of 0.38 is consistent with the value used for monomeric
anisotropy of GFP-tagged (via flexible linkers) to proteins
(26). In any event, it should be emphasized that the funda-
mental anisotropy of 5-HT1AR-EYFP (hereafter referred
to as the predicted anisotropy of the monomer) assumed
by us in this work merely serves as a reference to quantita-
tively monitor changes in the oligomeric state of the
receptor.
All anisotropies reported here were corrected for micro-
scopic aperture-induced depolarization (27,28) (see Mate-
rials and Methods, and inset in Fig. 1). We observed a
significantly low initial anisotropy of ~0.22 for 5-HT1AR-
EYFP in control cells (see Table 1 and Fig. 1). Since the
rotational correlation time of EYFP in solution is ~16 ns
(22), and the fluorescence lifetime of 5-HT1AR-EYFP isBiophysical Journal 100(2) 361–368
364 Ganguly et al.~3.5 ns (see below), it is unlikely that the depolarization of
emission is influenced by the rotational mobility of the flu-
orophore. We therefore attribute the depolarization of emis-
sion to energy transfer (homo-FRET) between oligomers of
5-HT1AR-EYFP molecules.
If the reduction in anisotropy is due to homo-FRET
induced by oligomerization, the anisotropy should increase
upon photodestruction of energy transfer acceptors (15).
Fig. 1 shows the plot of the average steady-state anisotropy
as a function of the extent of photobleaching of 5-HT1AR-
EYFP in CHO cells. An increase in fluorescence anisotropy
is observed, as expected for a system undergoing homo-
FRET. Assuming photobleaching to be random, the nature
of this plot can be deduced for various types of oligomers
from the theoretical formalism previously proposed by
Yeow and Clayton (14). Fig. 2 shows the predicted variation
of fluorescence anisotropy with increased photobleaching
for a homogeneous distribution of monomers, dimers,
trimers, and tetramers (assuming an anisotropy of 0.38
for monomers; see the Supporting Material for details).
In principle, the oligomeric state and inherent mobility of
the 5-HT1AR-EYFP complex can be obtained by fitting the
anisotropy bleaching data to the theoretical model. In that
case, the extrapolated anisotropy of 5-HT1AR-EYFP at the
100% photobleaching limit should reflect the inherent rota-
tional mobility of 5-HT1AR-EYFP (i.e., in the absence of
homo-FRET). However, it is difficult to achieve a very
high degree of fractional bleaching experimentally because
of possible cytotoxic effects and reduction in the signal/
noise ratio. To avoid these problems associated with highFIGURE 2 Simulation of anisotropy enhancement upon photobleaching
for a population of homogeneous oligomers containing N subunits.
N-values correspond to 1 (monomer, red —), 2 (dimer, light green —-),
3 (trimer, blue –– - - ––), and 4 (tetramer, deep green –– - ––). Simulations
were generated using the theoretical formalism developed by Yeow and
Clayton (14). The extrapolated anisotropies derived from initial points cor-
responding to fractional bleaching (<0.3) in the case of trimer and tetramer
are also shown (...). See Materials and Methods for other details.
Biophysical Journal 100(2) 361–368fractional bleaching, we compared the linearly extrapolated
anisotropy with the predicted anisotropy to infer the pres-
ence of higher-order oligomers (shown in Fig. 2). The closer
the extrapolated anisotropy is to the predicted anisotropy
(0.38), the higher is the fraction of dimeric population. On
the other hand, the larger the difference between the extrap-
olated and predicted anisotropy, the greater is the fraction of
higher-order (N > 2) oligomers. A comparison of Figs. 1
and 2 shows that although data for the serotonin1A receptor
under control conditions could be well fitted by a linear
model, the extrapolated and predicted anisotropies exhibit
a considerable difference (Table 1). Interestingly, the extrap-
olated anisotropy in control cells was found to be ~0.31 (see
Table 1). We therefore interpret the lower value of the
extrapolated anisotropy to be due to the presence of
higher-order (N > 2) oligomers of 5-HT1AR-EYFP (see
Fig. 2).Effect of ligand stimulation on receptor
oligomerization
To monitor the effect of ligand stimulation on oligomeriza-
tion of 5-HT1AR-EYFP, we measured the increase in fluo-
rescence anisotropy subsequent to photobleaching upon
treatment with agonist (serotonin) and antagonist (p-MPPI).
As shown in Fig. 1 and Table 1, the increase in anisotropy
upon photobleaching in both cases was linear, as observed
in the case of control cells. A comparison with the extrapo-
lated anisotropy in the case of ligand stimulation brings up
an interesting point (see Table 1 and Fig. 3). While the
extrapolated anisotropy increases (i.e., approaches theFIGURE 3 Difference between the extrapolated anisotropy (extrapolated
to complete photobleaching) and the predicted anisotropy of 5-HT1AR-
EYFP plotted under various conditions. The extrapolated anisotropy is esti-
mated from a linear fit of the photobleaching data (see Fig. 1 and Table 1).
With increasing oligomerization, the extrapolated anisotropy is expected to
increasingly deviate from the predicted anisotropy. The magnitude of devi-
ation provides a measure of the extent of oligomerization. See text for other
details.
Organization of Higher-Order GPCR Oligomers 365predicted anisotropy (~0.38)) in case of stimulation by the
antagonist (compared with the extrapolated anisotropy
observed for control cells), the extrapolated anisotropy
upon agonist stimulation is lower. These results suggest
that although antagonist treatment results in lowering the
fraction of higher-order oligomers compared with what is
present in control conditions, the agonist appears to induce
the formation of higher-order oligomers.Effect of cholesterol depletion on receptor
oligomerization
Cholesterol has been shown to improve the stability of
various GPCRs, such as the b2-adrenergic receptor (29),
and appears to be a necessary component for crystallization
of the receptor because it is believed to facilitate receptor-
receptor interaction and consequent oligomerization (30).
To explore the effect of membrane cholesterol on the oligo-
merization of 5-HT1AR-EYFP, we treated cells with the
cholesterol-depleting agent MbCD. As shown in Fig. 1 and
Table 1, the increase in anisotropy upon photobleaching in
MbCD-treated cells was linear. In the case of cholesterol-
depleted cells, the initial anisotropy (~0.26) appears to be
higher than in control cells (Table 1). The extrapolated
anisotropy, on the other hand, approaches much closer to
the predicted anisotropy (see Table 1 and Fig. 3). These
results imply the predominance of a receptor dimer popula-
tion in the cholesterol-depleted condition. In other words,
a fraction of higher-order oligomers (present under control
conditions) are reduced to dimers upon cholesterol depletion.
We therefore conclude that higher-order oligomers of the
receptor are more stringently regulated bymembrane choles-
terol than dimers.Actin cytoskeleton destabilization leads
to reorganization of the receptor oligomeric
population
We have previously shown that the actin cytoskeleton regu-
lates the mobility and signaling of the serotonin1A receptor
(31–33). To monitor the effects of the actin cytoskeleton
on receptor oligomerization, we measured the change in
5-HT1AR-EYFP anisotropy after photobleaching upon
destabilization of the actin cytoskeleton by CD. Interest-
ingly, actin cytoskeleton destabilization resulted in a very
different nature of the recovery of fluorescence anisotropy
upon photobleaching (Fig. 1 and Table 1). As shown in
the figure, the increase in anisotropy upon photobleaching
of the receptor was marginal in this case, in sharp contrast
to the above results. The initial anisotropy of 5-HT1AR-
EYFP was somewhat lower in CD-treated cells than in the
control condition. The trend in increase of anisotropy
upon photobleaching was very different under this condi-
tion. This becomes apparent upon comparison of the extrap-
olated anisotropy for actin destabilization with that obtainedunder other conditions (see Fig. 3 and Table 1). As shown in
the figure and table, the extrapolated anisotropy was consid-
erably lower than the predicted anisotropy, implying a
significant extent of receptor clustering into higher-order
oligomers. These results suggest that upon destabilization
of the actin cytoskeleton, the serotonin1A receptor
undergoes reorganization to form larger oligomers.Fluorescence lifetime of 5-HT1AR-EYFP in cells
The lifetime of a fluorophore is known to be sensitive to its
immediate environment (34). An image of the fluorescence
lifetime distribution of a given fluorophore in a cellular
milieu can provide location-specific environmental informa-
tion (35). We assessed the sensitivity of the fluorescence
lifetime of 5-HT1AR-EYFP under conditions described
above using frequency domain FLIM of live cells. The
spatial distribution of the fluorescence lifetime of
5-HT1AR-EYFP, color-coded on a scale of 0–4 ns, is shown
in Fig. 4. The phase and modulation lifetime images in
control cells show general agreement with average lifetimes
of 3.55 and 3.69 ns, respectively. The close agreement of the
phase and modulation lifetimes suggests that the EYFP flu-
orophore experiences an overall homogeneous environment
inside the cell (36). We did not observe any significant
distribution in the fluorescence lifetime of 5-HT1AR-EYFP
in the cell (Fig. 4), which suggests that the EYFP lifetime
is relatively insensitive to the cellular microenvironment
in which it is localized. This is not surprising considering
the fact that the fluorophore moiety of the GFP group of
proteins has been shown to be insensitive to the bulk envi-
ronment due to its compact b-barrel structure (37). In addi-
tion, the average fluorescence lifetime of 5-HT1AR-EYFP
remained invariant (see Table 2), even in conditions where
we observed maximal changes in receptor oligomerization
status (i.e., cholesterol depletion and actin cytoskeleton
destabilization; see Table 1). Importantly, these results
assume significance because the overall invariance of the
measured lifetime suggests that the anisotropy measure-
ments described above are not influenced by a change in
the fluorescence lifetime.Fluorescence anisotropy of 5-HT1AR-EYFP
in cells is independent of receptor expression
Oligomerization of membrane proteins can be induced by
trivial association due to overexpression of a given protein.
For example, it was previously reported that although neuro-
kinin-1 receptor may appear to oligomerize at higher
expression levels, it is monomeric at low levels of expres-
sion (11). To avoid such artifacts, we analyzed the depen-
dence of the measured initial anisotropy on receptor
expression levels. To that end, we measured the total fluo-
rescence intensity originating from a cell and the corre-
sponding anisotropy of the same cell. Data points from allBiophysical Journal 100(2) 361–368
FIGURE 4 Frequency domain FLIM of CHO-5-
HT1AR-EYFP cells. Panels A–C show the intensity
(blue: low, white: high), modulation, and phase
lifetime images (color-coded on a scale of 0–4 ns)
of untreated cells. Images represent the spatial
distribution of fluorescence intensity, modulation,
and phase lifetimes of 5-HT1AR-EYFP. Panels
D–F show the corresponding images of cells
treated with CD. See Materials and Methods for
other details.
366 Ganguly et al.treatments analyzed this way and the resulting scatter is
shown in Fig. 5. The figure shows that our data set includes
receptors that differ in expression levels by ~4-fold, since
we observe a similar fold change in fluorescence intensity.
Notably, the absence of any specific trend in the scatter
shows that the measured anisotropies were independent of
receptor expression level. We therefore conclude that the
oligomeric status of the serotonin1A receptor reported by
us is independent of the receptor expression levels.DISCUSSION
In this work, we monitored the oligomerization state of the
serotonin1A receptor using homo-FRET. On the basis of the
observed increase in fluorescence anisotropy upon progres-
sive photobleaching, and our analysis of data based on the
difference between the extrapolated anisotropy and the pre-
dicted anisotropy, we propose the presence of constitutive
oligomers of the serotonin1A receptor. Previous studies
focused on the oligomerization state of the serotonin1ATABLE 2 Comparison of phase and modulation lifetimes of
5-HT1AR-EYFP in live cells
Condition
Phase lifetime
t4 (5 SD) (ns)
Modulation lifetime
tM (5 SD) (ns)
Control 3.555 0.09 3.695 0.05
CD 3.545 0.03 3.665 0.02
MbCD 3.465 0.06 3.665 0.04
See Materials and Methods for other details.
Biophysical Journal 100(2) 361–368receptor (38–40) using either hetero-FRET (39,40) or coim-
munoprecipitation (38). As noted above, hetero-FRET
suffers from a number of limitations, and immunological
approaches are susceptible to cross-reactivity. In our
work, we utilized homo-FRET, which is free from theseFIGURE 5 Fluorescence intensity from a large number of measurements
(N > 25) plotted against the corresponding values of initial anisotropy. The
plotted points represent data collected under conditions described in Fig. 1
(untreated cells (C, black) and cells treated with serotonin (:, red),
p-MPPI (;, cyan), CD (-, blue), or MbCD (A, green)). It is apparent
that there is no systematic variation of anisotropy with intensity (receptor
number). See Materials and Methods for other details.
Organization of Higher-Order GPCR Oligomers 367limitations. A unique advantage of homo-FRET is that it
allows one to detect higher-order oligomers along with
dimers (14). To our knowledge, this study is the first to
suggest the presence of higher-order oligomers of the sero-
tonin1A receptor. Interestingly, such higher-order oligomers
have recently been implicated in the case of the EGF
receptor (41). In addition, we report the reorganization of
higher-order oligomers in response to ligand activation,
membrane cholesterol depletion, and actin cytoskeleton
destabilization (see Fig. 6).
We observe that agonist (serotonin) stimulation and
cytoskeletal destabilization appear to reduce the initial
anisotropy, whereas antagonist (p-MPPI) treatment and
cholesterol depletion lead to an increase in initial anisot-
ropy. In addition, the difference between the extrapolated
anisotropy and the predicted anisotropy is greater for
agonist stimulation and cytoskeletal destabilization, and
less for antagonist treatment and cholesterol depletion
(Fig. 3). These results suggest that antagonist treatment
and cholesterol depletion effectively reduce the population
of higher-order oligomers. In contrast, agonist stimulation
and destabilization of the actin cytoskeleton lead to an
increased contribution from higher oligomers (see Fig. 6).
Importantly, the increase in anisotropy upon photobleaching
remains linear within experimental limits in all cases, sug-
gesting the significant presence of dimers. In the case of
actin cytoskeleton destabilization, we observe a major loss
in recovery in anisotropy upon photobleaching and a severe
reduction in the extrapolated anisotropy (Fig. 1). This could
be interpreted as resulting from the formation of larger
oligomers under this condition.
Our current understanding of the organization of biolog-
ical membranes involves the concept of lateral heterogene-FIGURE 6 Schematic model of the oligomeric status of the serotonin1A
receptor. The model assumes an initial state of heterogeneous oligomers of
the receptor in an untreated (control) cell membrane. Upon activation with
agonist or destabilization of the actin cytoskeleton, receptors tend to form
oligomeric structures of higher order (>2 monomers/cluster). Antagonist
treatment or cholesterol depletion appears to increase the fraction of
receptor population in the dimeric state. See text for other details.ities in the membrane, collectively termed as membrane
domains (42,43). These lateral heterogeneities are further
modulated by cholesterol and actin cytoskeleton. A compre-
hensive understanding of cellular signaling would therefore
require the mapping of membrane heterogeneity at both
spatial and temporal scales under these conditions. In view
of the overall spatiotemporal heterogeneity of the eukary-
otic plasma membrane, it is conceivable that segregated
domains of the plasma membrane can harbor different olig-
omeric forms of GPCRs. The total population of receptors
could therefore exist in a dynamic equilibrium between
such domains. In view of the enormous implications of
GPCR function in human health, progress in elucidating
the oligomerization status of GPCRs would enhance our
ability to design better therapeutic strategies to combat
diseases related to malfunctioning of these receptors.SUPPORTING MATERIAL
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